CAN (BC): Abattis announces receipt of cultivation license by LP partner

Abattis and its majority-owned testing and laboratory subsidiary, Northern Vine Canada, announce that their Licensed Producer (LP) investment partner, Experion Biotechnologies, has officially received an Access to Cannabis for Medical Purposes Regulations cultivation license from Health Canada to grow medicinal marijuana at its newly-completed facility located in Mission, BC.

“Abattis and Northern Vine would like to congratulate Experion on receiving its cultivation license and officially becoming a legal cannabis producer in British Columbia,” said Robert Abenante, President and CEO of Abattis and Northern Vine.

The cultivation license follows Experion’s construction of an indoor secure storage and processing facility, known as the Mission Site. The Mission Site is approximately 8,300 square feet in total, with a portion being used to grow medical-grade marijuana. Experion has already announced plans to expand its production facility to 40,000 square feet, subject to Health Canada approval.

“This is very positive news for Experion and for Northern Vine,” added Mr. Abenante.

Abattis is the majority owner of Northern Vine, which holds an 18.75% equity stake in Experion.

Due to receipt of its license, Experion is now officially designated by Health Canada as a Licensed Producer, becoming only the 13th licensed producer in British Columbia.

For more information:
www.abattis.com
www.northernvinelabs.com